Surgical Closure of a Large Palatal Fistula - New Line · PDF fileCASE REPO R T MKT001-02.A...
2
CASE REPORT MKT001-02.A Figure 3 Figure 5 J. Jerome Smith, DDS Lafayette, LA Surgical Closure of a Large Palatal Fistula A 30 year old male presented with an oral antral fistula (12 mm X 10 mm) in the mid-palate secondary from a motor vehicle accident 5 years previous (Figure 1). Soon after the accident, another practitioner's attempt to close the fistula failed. Since that time, the patient had been fitted for an obturator. Under conscious sedation and local anesthesia, the palatal soft tissue was excised from third molar to third molar area and reflected posteriorly. The circumferential margins of the fistula orifice were de-epithelialized and closed together with 5/0 Ethicon sutures (Figure 2). A resorbable collagen membrane was placed and secured over the bony defect along with several platelet rich fibrin membranes prior to closure of the semi-circumferential palatal incision. An impression was made immediately after surgical wound closure to fabricate an appliance complete with reservoir for application of Periogenix directly over the surgical site (Figure 3). Post operative instructions included wearing the appliance 24 hours and dispensing Periogenix in the appliance reservoir t.i.d. At three days post-op recall (Figure 4), the sutured fistula as well as the palatal incision showed remarkable healing and appeared to be in an advanced state of healing characteristically seen at 7 to 8 days post-op. The patient continued to wear the appliance on an ongoing basis and used Periogenix as instructed for three weeks post-op (Figure 5). Examination indicated that the integrity of the incision was sound and healing continued to show remarkable results. The patient required minimal post-op analgesia and the fistula closure was a complete success (Figure 6). For more information about OroScience products and technologies, please email [email protected] or call 1.650.856.9600 or toll free 1.866.921.9603 www.oroscience.com Figure 1 Figure 2 Figure 4 Figure 6
Transcript of Surgical Closure of a Large Palatal Fistula - New Line · PDF fileCASE REPO R T MKT001-02.A...
CASE REPORT
MKT001-02.A
F igure 3
F igure 5
J. Jerome Smith, DDSLafayette, LA
Surgical Closure of a Large Palatal Fistula
A 30 year old male presented with an oral antral fistula (12 mm X 10 mm) in themid-palate secondary from a motor vehicle accident 5 years previous (Figure 1).Soon after the accident, another practitioner's attempt to close the fistula failed.Since that time, the patient had been fitted for an obturator.
Under conscious sedation and local anesthesia, the palatal soft tissue wasexcised from third molar to third molar area and reflected posteriorly. The circumferential margins of the fistula orifice were de-epithelialized andclosed together with 5/0 Ethicon sutures (Figure 2). A resorbable collagenmembrane was placed and secured over the bony defect along with severalplatelet rich fibrin membranes prior to closure of the semi-circumferentialpalatal incision.
An impression was made immediately after surgical wound closure to fabricatean appliance complete with reservoir for application of Periogenix directly overthe surgical site (Figure 3).
Post operative instructions included wearing the appliance 24 hours anddispensing Periogenix in the appliance reservoir t.i.d.
At three days post-op recall (Figure 4), the sutured fistula as well as the palatalincision showed remarkable healing and appeared to be in an advanced stateof healing characteristically seen at 7 to 8 days post-op.
The patient continued to wear the appliance on an ongoing basis and usedPeriogenix as instructed for three weeks post-op (Figure 5). Examinationindicated that the integrity of the incision was sound and healingcontinued to show remarkable results. The patient required minimal post-opanalgesia and the fistula closure was a complete success (Figure 6).
For more information about OroScience products and technologies, please email [email protected] or call 1.650.856.9600 or toll free 1.866.921.9603
www.oroscience.com
F igure 1
F igure 2
F igure 4 F igure 6
Periogenix™ is intended to protect injuredperiodontal tissue by forming a temporary physical barrier to avoid further irritation.
Periogenix™ helps the clinician manage oral wounds by providing a barrier to assist in the process of acute and chronic wound healing. Clinical and animal studies demonstrate that Periogenix™ protects and safelypromotes the healing of post-operative surgical wounds
Periogenix™ is a prescription product that is packagedas a wound dressing kit consisting of a pressurizedcanister containing 30 mL (1 US ounce) of emulsion and 30 disposable dental trays. The Periogenix™ emulsion is dispensed into the disposable dental tray and placed over the dental arch three times daily to manage acuteand chronic wounds. One Periogenix™ Kit is used at-home by the patient over a 7 to 10 day period or as prescribed by the oral care practitioner.
Periogenix™ Emulsion IngredientsPeriogenix™ contains perfluorodecalin, purified water,glycerin, hydrogenated phosphatidylcholine, cetearyl
alcohol, polysorbate 60, tocopheryl acetate, benzyl alcohol, methylparaben, propylparaben, & oxygen.
Available in the US onlyFor Prescription Use Only in the United StatesFederal Law restricts this device to sale by or on theorder of a dentist, physician or properly licensed
practitioner.
Directions and Indications for UseSee Directions for Use for full discussion of indications, directions, contraindications, and warnings.
www.oroscience.comFor more information about OroScience products andtechnologies, please email [email protected] call 1.650.856.9600 or toll free 1.866.921.9603MKT001-02.A
![Percutaneous Transcatheter Closure of Perimembranous ...for muscular VSD (VSDM) [3], since in the gold standard treatment for the perimembranous VSD is surgical closure with the use](https://static.fdocuments.in/doc/165x107/6031c4818186ce46207215b8/percutaneous-transcatheter-closure-of-perimembranous-for-muscular-vsd-vsdm.jpg)
